Genetic Risk for Major Depression Linked to Lower Self-Esteem Prior to Severe Diagnosis

A recent study published in *Molecular Psychiatry* reveals a significant connection between genetic risk for major depression and lower self-esteem, observed years before individuals required severe clinical treatment. Conducted by researchers from Oslo University Hospital and the University of Oslo, the study analyzed data from the Norwegian Mother, Father and Child Cohort Study, which included 105,623 participants over a 16-year follow-up period.

Psypost

The research utilized polygenic risk scores, which summarize an individual's estimated genetic risk for major depression, bipolar disorder, and schizophrenia. The findings indicated that 31.1 percent of participants received a diagnosis related to the depression spectrum during the study period. Notably, individuals with higher polygenic risk scores for major depression were more likely to experience severe forms of the disorder, particularly those requiring inpatient hospitalization.

Psypost

Self-reported questionnaires, including the Symptom Checklist-5 and the Rosenberg Self-Esteem Scale, revealed that higher genetic risk correlated with increased emotional distress, lower life satisfaction, and notably, lower self-esteem. This association was particularly pronounced in individuals who later required inpatient care, suggesting that genetic predisposition may influence psychological well-being long before clinical diagnosis.

Psypost

Lead researcher Marit Haram emphasized the potential of using genetic risk scores to predict illness outcomes and guide personalized treatment. However, she cautioned that these scores are not yet robust enough for clinical application. The study's results indicate that genetic risk for major depression may serve as a predictive marker for individuals at risk of developing severe mental health issues.

Psypost

Despite the study's insights, there are limitations to consider. The reliance on medical registry data, which became fully available only in 2008, may have led to underreporting of earlier depressive episodes. Additionally, the cohort's higher socioeconomic status could influence the findings, particularly regarding the genetic markers for height, which showed a slight negative correlation with depression diagnoses.

Psypost

Haram noted, “We cannot say that the genetic risk is ready for use in the clinical context yet. But our proof-of-principle results show that further development of polygenic scores for major depression for the current clinical use case is worth pursuing.” Future research is necessary to refine these genetic risk calculations and explore their integration into clinical practice.

Psypost

• “Depressive disorders are common in the population, but the symptom expression and course of the disorders vary quite a bit between individuals.” — Marit Haram, Lead Researcher

Psypost

• “The finding illustrates that individuals who developed more severe depression carry a greater genetic burden, which influences their answers on self-report measures in a different timeframe than the registered depression,” — Marit Haram

Psypost

• “This could indicate that the genetic risk for depression shows the strongest predictive potential in populations of individuals who will develop severe mental disorders.” — Marit Haram

Psypost

This study highlights the complex interplay between genetics and mental health, paving the way for future advancements in personalized treatment approaches for major depression.

Psypost